Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2025-02-03

EMA Authorised: Fortacin (lidocaine;prilocaine) — Recordati Ireland Ltd.

View source ↗

Summary

The EMA authorised Fortacin, a lidocaine/prilocaine topical product from Recordati Ireland Ltd., for the treatment of premature ejaculation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fortacin (lidocaine; prilocaine)

Snippet

Status: Authorised. Therapeutic area: Sexual Dysfunction, Physiological. MAH: Recordati Ireland Ltd.. Decision date: 31/01/2025